CNR Institutional Research Information System

RASI, GUIDO

RASI, GUIDO  

FARMACOLOGIA TRASLAZIONALE - IFT  

Mostra records
Risultati 1 - 20 di 83 (tempo di esecuzione: 0.028 secondi).
Titolo Data di pubblicazione Autore(i) File
A new human tumor-associated antigen (TLP) is naturally expressed in rat DHD-K12 colorectal tumor cells. 1-gen-2000 Rasi, G; Sinibaldivallebona, P; Serafino, A; Bernard, P; Pierimarchi, P; Guarino, E; Faticantiscucchi, L; Graziano, P; Guadagni, F; Garci, E
Analysis of Melan-A/MART-1 antigen expression during differentiation induced by Cyanidin-3-O-B glucopyranoside in human melanoma cells 1-gen-2005 Zonfrillo M.; Serafino A. ; Andreola F.; Rasi G. ; SinibaldiVallebona P.; Pierimarchi P .
Anti-tumor effect of combined treatment with thymosin alpha 1 and interleukin-2 after 5-fluorouracil in liver metastases from colorectal cancer in rats. 1-gen-1994 Rasi, G; Silecchia, G; Sinibaldivallebona, P; Spaziani, E; Pierimarchi, P; Sivilia, M; Tremiterra, S; Garaci, E
Antitumoral immunogenic peptides and vaccine thereof 1-gen-2005 Fazio V. M.; Garaci E.; Rasi G.; Rinaldi M.; Sinibaldi P.
AQUA: Allergy Questionnaire for Athletes. Development and validation 1-gen-2009 Bonini, M; Braido, F; Baiardini, I; Del Giacco, S; Gramiccioni, C; Manara, M; Tagliapietra, G; Scardigno, A; Sargentini, V; Brozzi, M; Rasi, G; Bonini, S
Atrial Natriuretic peptide inhibits colorectal cancer cell growth by reverting the WNT/beta catenin pathway 1-gen-2008 Serafino, A; Pierimarchi, P; Andreola, F; Mercuri, L; Psaila, R; Zonfrillo, M; Garaci, E; Rasi, G
Autoimmune Hepatitis 1-gen-2003 Rasi, G
Combination low-dose lymphoblastoid interferon and thymosin alpha 1 therapy in the treatment of chronic hepatitis B. 1-gen-1996 Rasi G; Mutchnick MG; Di Virgilio D; SinibaldiVallebona P; Pierimarchi P; Colella F; Favalli C; Garaci E.
Combination therapy in the treatment of chronic viral hepatitis 1-gen-2003 Rasi, G
Combination therapy in the treatment of chronic viral hepatitis and prevention of hepatocellular carcinoma 1-gen-2003 Rasi, G; Pierimarchi, P; Sinibaldivallebona, P; Colella, F; Garaci, E
Combination Therapy of cancer. Experimental Models 1-gen-2003 Rasi G.
Combination thymosin alpha 1 and lymphoblastoid interferon treatment in chronic hepatitis C. 1-gen-1996 Rasi, G; Divirgilio, D; Mutchnick, Mg; Colella, F; Sinibaldivallebona, P; Pierimarchi, P; Valli, B; Garaci, E
Combined treatment with thymosin-alpha1 and low dose interferon-alpha after dacarbazine in advanced melanoma. 1-gen-2000 Rasi G; Terzoli E; Izzo F; Pierimarchi P; Ranuzzi M; SinibaldiVallebona P; Tuthill C; Garaci E.
Comparative cellular signal pathway analysis of metastatic colorectal cancer in human and preclinical animal model 1-gen-2008 Moroni, M; Pierobon, M; Galdi, F; Belluco, C; Zonfrillo, M; Pierimarchi, P; Serafino, A; Nitti, D; Garaci, E; De Maria, R; Liotta, L; Petricoin, E; Rasi, G
Conjunctival expression of thymosin-â4 in vernal keratoconjunctivitis. 1-gen-2006 Micera, A; Bonini, S; Lambiase, A; Lapucci, G; Bonini, S; Rasi, G
Cytoplasmic localization of anthracycline antitumor drugs conjugated with reduced glutathione: a possible correlation with multidrug resistance mechanisms 1-gen-1998 A. Serafino; P. SinibaldiVallebona; G. Gaudiano; T.H. Koch; G. Rasi; E. Garaci;G. Ravagnan
Determinazione della specificità della risposta CTL verso TAA/TSA human shared in seguito a trattamento chemio-immunoterapico 1-gen-2003 Rasi G.
Development and application of innovative in vitro/in vivo models for the evaluation of new diagnostic and/or therapeutic approaches of human cancer with particular focus on cancer vaccines 1-gen-2004 Rasi G.
Development of immunoisolated cells implants for locoregional therapy in a colorectal cancer preclinical model 1-gen-2005 Rasi, G
Development of immunoisolated cells implants for locoregional therapy in a colorectal cancer preclinical model 1-gen-2006 Rasi, G